Related Experiment Video
Updated: Jan 5, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Amyloid-β-Dependent Inactivation of the Mitochondrial Electron Transport Chain at Low Transmembrane Potential: An
1Lions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA.
Abstract:
Cerebral hypoperfusion-induced hypoxia, a condition that impairs oxygen utilization and thus ATP production by mitochondrial oxidative phosphorylation (oxphos), is thought to contribute to neural degeneration in Alzheimer's disease. However, hypoxia upregulates the generation of amyloid-β (Aβ), a group of peptides known to impair/inhibit the electron transport chain (ETC) of reactions that support oxphos in the inner mitochondrial membrane (IMM). This is a hypothesis paper that reconciles the hypoxia-induced upregulation of Aβ with Aβ's ETC-inhibiting action and, specifically, posits an oxphos-enhancing effect of this inhibition under conditions of newly developing or otherwise mild hypoxia. This effect is typically transient; that is, under conditions of prolonged or severe hypoxia, the oxphos-enhancing activity is overwhelmed by Aβ's well-known toxic actions on mitochondria and other cellular components. The hypothesis is motivated by evidence that the IMM transmembrane potential Ψm, an important determinant of ETC activity, exhibits heterogeneity, i.e., a range of values, among a given local population of mitochondria. It specifically proposes that during oxygen limitation, Aβ selectively inactivates ETC complexes in mitochondria that exhibit relatively low absolute values of Ψm, thereby suppressing oxygen binding and consumption by complex IV of the ETC in these mitochondria. This effect of Aβ on low-Ψm mitochondria is hypothesized to spare hypoxia-limited oxygen for oxphos-enabling utilization by the ETC of the remaining active, higher-Ψm local mitochondria, and thereby to increase overall ATP generated collectively by the local mitochondrial population, i.e., to ameliorate hypoxia-induced oxphos reduction. The protective action of Aβ hypothesized here may slow the early development of hypoxia-associated cellular deterioration/loss in Alzheimer's disease and perhaps other neurodegenerative diseases.
Insights
Hypoxia in Alzheimer's disease may be counteracted by amyloid-beta (Aβ) peptides. This peptide temporarily enhances ATP production by selectively inhibiting mitochondria with low membrane potential, sparing oxygen for healthier mitochondria.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Biochemistry
Background:
- Cerebral hypoperfusion causes hypoxia, impairing ATP production via mitochondrial oxidative phosphorylation (oxphos) and contributing to neurodegeneration in Alzheimer's disease (AD).
- Hypoxia paradoxically increases amyloid-beta (Aβ) production, a peptide known to inhibit the electron transport chain (ETC) essential for oxphos.
Purpose of the Study:
- To reconcile the hypoxia-induced upregulation of Aβ with its ETC-inhibiting properties.
- To propose a novel hypothesis where Aβ enhances oxphos under mild hypoxia by selectively targeting mitochondria.
Main Methods:
- This is a hypothesis paper, not an experimental study.
- It integrates existing evidence on mitochondrial transmembrane potential (Ψm) heterogeneity and Aβ's effects on the ETC.
- The hypothesis focuses on the selective inactivation of ETC complexes in low-Ψm mitochondria by Aβ.
Main Results:
- Under mild hypoxia, Aβ is hypothesized to selectively inactivate ETC complexes in mitochondria with lower Ψm.
- This action spares oxygen for ETC utilization in higher-Ψm mitochondria, potentially boosting overall ATP production.
- This transient, protective effect may mitigate early hypoxia-associated neurodegeneration in AD.
Conclusions:
- Aβ may exert a transient, protective role in early AD by optimizing mitochondrial function under hypoxic stress.
- This proposed mechanism highlights a potential therapeutic window for targeting Aβ's interaction with mitochondria.
- Further research is needed to experimentally validate this hypothesis in neurodegenerative disease models.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Mitochondria
ATP Synthase: Mechanism
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes

